Literature DB >> 19207643

First evaluation of six nucleic acid amplification tests widely used in the diagnosis of Chlamydia trachomatis in Russia.

E Shipitsyna1, E Zolotoverkhaya, I Agné-Stadling, A Krysanova, A Savicheva, E Sokolovsky, M Domeika, M Unemo.   

Abstract

BACKGROUND: In Russia, nationally developed nucleic acid amplification tests (NAATs), which have never been validated to international commercially available NAATs, are mainly used in the diagnosis of Chlamydia trachomatis infection.
OBJECTIVE: To evaluate the performance characteristics of six NAATs widely used to diagnose C. trachomatis infection in Russia.
MATERIALS AND METHODS: In total, 446 consecutive symptomatic patients (319 females and 127 males) were included. Five polymerase chain reaction (PCR) assays and one real-time nucleic acid sequence-based amplification (NASBA) assay were evaluated on cervical and vaginal samples from females and on urethral and first voided urine samples from males. As reference methods, the Cobas Amplicor PCR, as the main 'gold standard' method, and LightMix 480HT PCR were used.
RESULTS: The overall prevalence of C. trachomatis infection was 12.6%. The Russian NAATs and the reference methods displayed a high level of concordance (97.9% to 99.2%). In comparison with the reference methods, the sensitivities, specificities, positive predictive values and negative predictive values of the Russian tests in different specimens ranged from 86.1% to 100%, 99.1% to 100%, 92.3% to 100% and 98.2% to 100%, respectively.
CONCLUSIONS: According to the reference methods, C. trachomatis NAATs developed and used in Russia have relatively good performance characteristics for both invasive and non-invasive samples. However, larger studies that include symptomatic and asymptomatic patients as well as genital and extra-genital samples, and in comparison with other internationally well-recognized, validated, and ideally Food and Drug Administration-approved C. trachomatis NAATs performed strictly according to the manufacturer's instructions, need to be conducted.

Entities:  

Mesh:

Year:  2008        PMID: 19207643     DOI: 10.1111/j.1468-3083.2008.03038.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  6 in total

1.  Evaluation of a novel Chlamydia trachomatis microsphere suspension assay for detection and genotyping of the different serovars in clinical samples.

Authors:  Koen D Quint; Daan T Geraets; Henk A M van den Munckhof; Maurits N C de Koning; Vitaly Smelov; Willem J G Melchers; Henry J C de Vries; Servaas A Morré; Chris J M Meijer; Dirk C J G van Alewijk; Leen-Jan van Doorn; Wim G V Quint
Journal:  J Mol Diagn       Date:  2011-03       Impact factor: 5.568

2.  Sexually transmitted infections among HIV-infected heavy drinkers in St Petersburg, Russia.

Authors:  C A Pace; D Lioznov; D M Cheng; S E Wakeman; A Raj; A Y Walley; S M Coleman; C Bridden; E Krupitsky; J H Samet
Journal:  Int J STD AIDS       Date:  2012-12       Impact factor: 1.359

3.  Bacterial vaginosis-associated vaginal microbiota is an age-independent risk factor for Chlamydia trachomatis, Mycoplasma genitalium and Trichomonas vaginalis infections in low-risk women, St. Petersburg, Russia.

Authors:  Elena Shipitsyna; Tatiana Khusnutdinova; Olga Budilovskaya; Anna Krysanova; Kira Shalepo; Alevtina Savicheva; Magnus Unemo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-02-08       Impact factor: 3.267

4.  Evaluation of the performance of nucleic acid amplification tests (NAATs) in detection of chlamydia and gonorrhoea infection in vaginal specimens relative to patient infection status: a systematic review.

Authors:  Minttu M Rönn; Louise Mc Grath-Lone; Bethan Davies; Janet D Wilson; Helen Ward
Journal:  BMJ Open       Date:  2019-01-17       Impact factor: 2.692

5.  Treatment efficacy, treatment failures and selection of macrolide resistance in patients with high load of Mycoplasma genitalium during treatment of male urethritis with josamycin.

Authors:  Alexander Guschin; Pavel Ryzhikh; Tatiana Rumyantseva; Mikhail Gomberg; Magnus Unemo
Journal:  BMC Infect Dis       Date:  2015-02-03       Impact factor: 3.090

6.  First Detection of Chlamydia trachomatis 'Swedish' Variant (nvCT) in a Russian Couple with Infertility.

Authors:  Valentina Feodorova; Edgar Sultanakhmedov; Yury Saltykov; Sergey Zaitsev; Sergey Utz; Michael Corbel; Charlotte Gaydos; Thomas Quinn; Vladimir Motin
Journal:  Open Microbiol J       Date:  2018-10-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.